Mitesh

Following discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (20/12/2023) announced the following list of price concessions for December 2023. Community Pharmacy England has received a large number of reports of products not available at their Drug [...]

The post December 2023 Price Concessions 2nd Update appeared first on Community Pharmacy England.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Glucagon (GlucaGen®) 1mg powder for injection kit . MSN/2023/051 Tier 2 – medium impact Date of issue 18th December 2023 There are two licensed glucagon preparations: GlucaGen® (1mg powder for injection kit) and Ogluo® (0.5mg and 1mg pre-filled auto-injector pens) There [...]

The post Medicine Supply Notification: Glucagon (GlucaGen®) 1mg powder for injection kit appeared first on Community Pharmacy England.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Oxybutynin 5mg modified-release tablets. MSN/2023/116 Tier 2 – medium impact Date of issue 18th December 2023 Oxybutynin 5mg modified-release tablets are out of stock until early April 2024. Oxybutynin immediate release formulations (tablets and liquid) remain available and can support increased [...]

The post Medicine Supply Notification: Oxybutynin 5mg modified-release tablets appeared first on Community Pharmacy England.

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 17 Issue 5 December 2023) has been published and includes articles on: Aripiprazole (Abilify and generic brands): risk of pathological gambling Vitamin B12 (hydroxocobalamin, cyanocobalamin): advise patients with known cobalt allergy to be vigilant for sensitivity reactions Letters and medicine recalls sent [...]

The post MHRA Drug Safety Update: December 2023 appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has via its Central Alerting System (CAS) published a letter on 14 December 2023 advising that due to increasing flu levels in the community, Prescribers working in primary care may now prescribe, and community pharmacists may now supply antiviral medicines (oseltamivir and zanamivir) for the prophylaxis and treatment [...]

The post DHSC permits use of antiviral medicines against influenza appeared first on Community Pharmacy England.